ESR1 and breast neoplasm: Many key issues remain to be addressed, however, using these initial inventories of responsive genes, including overall conservation of responses across cell lines, in vivo relevance in breast tumors, and cis-regulatory element mapping and molecular characterization and confirmation of the interaction between ER and putative target genes.